HIGHLIGHTS
- who: Ana García-Álvarez from the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain have published the Article: Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension, in the Journal: (JOURNAL)
- what: Given that these biological functions are critical in pulmonary hypertension (PH) the authors aimed to demonstrate a beneficial effect of b3AR agonists in This is the first study of a broad project aimed to evaluate the clinical relevance of this potential new therapy (current study) and the mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.